Clearmind Medicine Inc. (CMND)
NASDAQ: CMND
· Real-Time Price · USD
0.95
0.00 (0.38%)
At close: Oct 16, 2025, 3:53 PM
0.95
0.27%
After-hours: Oct 16, 2025, 07:59 PM EDT
0.38% (1D)
| Bid | 0.94 |
| Market Cap | 5.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.83M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -1.26 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.95 |
| Volume | 26,020 |
| Avg. Volume (20D) | 748,181 |
| Open | 0.95 |
| Previous Close | 0.95 |
| Day's Range | 0.94 - 0.96 |
| 52-Week Range | 0.80 - 2.18 |
| Beta | -1.23 |
| Ex-Dividend Date | n/a |
About CMND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMND
Website n/a
3 weeks ago
+19%
Clearmind Medicine shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+21.82%
Clearmind Medicine shares are trading higher after the company announced IRB approval for its Phase 1/2a clinical trial for alcohol use disorder at Tel Aviv Sourasky Medical Center.
